Lupus Nephritis

被引:27
|
作者
Wenderfer, Scott E. [1 ]
Eldin, Karen W. [2 ]
机构
[1] Texas Childrens Hosp, Baylor Coll Med, Pediat Nephrol, Dept Pediat, 1102 Bates Ave,Suite 245, Houston, TX 77030 USA
[2] Texas Childrens Hosp, Baylor Coll Med, Dept Pathol & Immunol, 6621 Fannin St,Suite AB195, Houston, TX 77030 USA
关键词
Lupus; Nephritis; Glomerulopathy; Complement; Autoantibody; Proteinuria; Hematuria; Biopsy; STAGE RENAL-DISEASE; MYCOPHENOLATE-MOFETIL; RHEUMATOID-ARTHRITIS; INDUCTION TREATMENT; ERYTHEMATOSUS; ONSET; OUTCOMES; THERAPY; CHILDREN; EFFICACY;
D O I
10.1016/j.pcl.2018.08.007
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Childhood-onset systemic lupus erythematosus (SLE) is a subset of SLE with an onset before 18 years of age. Patients with early onset SLE tend to have a greater genetic component to their disease cause, more multisystemic involvement, and a more severe disease course, which includes greater risks for developing nephritis and end-stage kidney disease. Five- and 10-year mortality is lower than in adult-onset SLE. Although patient and renal survival have improved with advances in induction and maintenance immunosuppression, accumulation of irreversible damage is common. Cardiovascular and infectious complications are frequent, as are relapses during adolescence and the transition to adulthood.
引用
收藏
页码:87 / +
页数:15
相关论文
共 50 条
  • [1] Approach to Classification and Management of Childhood-Onset Lupus Nephritis
    Wenderfer, Scott E.
    Chang, Joyce
    Hicks, M. John
    CURRENT PEDIATRICS REPORTS, 2020, 8 (01) : 26 - 35
  • [2] The treatment of systemic lupus proliferative nephritis
    Punaro, Marilynn G.
    PEDIATRIC NEPHROLOGY, 2013, 28 (11) : 2069 - 2078
  • [3] Do we really need cyclophosphamide for lupus nephritis?
    Wenderfer, Scott E.
    Cooper, Jennifer C.
    PEDIATRIC NEPHROLOGY, 2024, 39 (11) : 3193 - 3200
  • [4] Treatment of lupus nephritis: practical issues in Asian countries
    Yap, Desmond Y. H.
    Chan, Tak Mao
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2015, 18 (02) : 138 - 145
  • [5] Management of proliferative lupus nephritis
    Monroy Trujillo, Jose M.
    Fine, Derek M.
    PANMINERVA MEDICA, 2016, 58 (04) : 286 - 293
  • [6] Lupus nephritis
    Schreiber, J.
    Eisenberger, U.
    de Groot, K.
    INTERNIST, 2019, 60 (05): : 468 - 477
  • [7] Rituximab use as induction therapy for lupus nephritis: a systematic review
    Stolyar, Liya
    Lahita, Robert G.
    Panush, Richard S.
    LUPUS, 2020, 29 (08) : 892 - 912
  • [8] Lupus nephritis: from diagnosis to treatment
    Weinmann-Menke, Julia
    INNERE MEDIZIN, 2023, : 225 - 233
  • [9] Con: Cyclophosphamide for the treatment of lupus nephritis
    Mok, Chi Chiu
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 (07) : 1053 - 1057
  • [10] Managing Lupus Nephritis in Children and Adolescents
    Chan, Eugene Yu-hin
    Lai, Fiona Fung-yee
    Ma, Alison Lap-tak
    Chan, Tak Mao
    PEDIATRIC DRUGS, 2024, 26 (02) : 145 - 161